ARRAY BIOPHARMA INC Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC for December 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 10.92 | 168,000 | 1,834,560 | 168,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 10.92 | 168,000 | 1,834,560 | 168,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 4,387 | 0 | 13,163 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Payment of Exercise | F | 10.92 | 2,044 | 22,320 | 22,343 | 24.4 K to 22.3 K (-8.38 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 0.00 | 4,387 | 0 | 24,387 | 20 K to 24.4 K (+21.94 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 4.63 | 87,500 | 405,125 | 87,500 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 4.91 | 89,634 | 440,103 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 4.91 | 20,366 | 99,997 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 5.14 | 200,000 | 1,028,000 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | A | 10.92 | 335,250 | 3,660,930 | 335,250 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | A | 0.00 | 55,875 | 0 | 55,875 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 13,082 | 0 | 39,249 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | S | 10.72 | 282,874 | 3,032,409 | 158,298 | 441.2 K to 158.3 K (-64.12 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 4.63 | 87,500 | 405,125 | 441,172 | 353.7 K to 441.2 K (+24.74 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 4.91 | 89,634 | 440,103 | 353,672 | 264 K to 353.7 K (+33.95 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 4.91 | 20,366 | 99,997 | 264,038 | 243.7 K to 264 K (+8.36 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 5.14 | 200,000 | 1,028,000 | 243,672 | 43.7 K to 243.7 K (+457.96 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Payment of Exercise | F | 10.92 | 6,094 | 66,546 | 43,672 | 49.8 K to 43.7 K (-12.25 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 0.00 | 13,082 | 0 | 49,766 | 36.7 K to 49.8 K (+35.66 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | A | 10.92 | 168,000 | 1,834,560 | 168,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 5,468 | 0 | 16,407 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 10.92 | 2,548 | 27,824 | 54,521 | 57.1 K to 54.5 K (-4.46 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 0.00 | 5,468 | 0 | 57,069 | 51.6 K to 57.1 K (+10.60 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 5.94 | 333,165 | 1,979,000 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 4.63 | 79,688 | 368,955 | 345,312 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 3.61 | 133,380 | 481,502 | 755,820 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 3.61 | 110,800 | 399,988 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 5.94 | 16,835 | 100,000 | 0 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 7.30 | 226,874 | 1,656,180 | 226,876 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | A | 10.92 | 600,000 | 6,552,000 | 600,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 23,437 | 0 | 70,313 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 10.93 | 546,233 | 5,970,327 | 209,274 | 755.5 K to 209.3 K (-72.30 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 5.94 | 333,165 | 1,979,000 | 755,507 | 422.3 K to 755.5 K (+78.89 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 4.63 | 79,688 | 368,955 | 422,342 | 342.7 K to 422.3 K (+23.26 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 3.61 | 133,380 | 481,502 | 342,654 | 209.3 K to 342.7 K (+63.73 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 10.73 | 273,438 | 2,933,990 | 209,274 | 482.7 K to 209.3 K (-56.65 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 3.61 | 110,800 | 399,988 | 482,712 | 371.9 K to 482.7 K (+29.79 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 5.94 | 16,835 | 100,000 | 371,912 | 355.1 K to 371.9 K (+4.74 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 7.30 | 226,874 | 1,656,180 | 355,077 | 128.2 K to 355.1 K (+176.96 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 10.92 | 10,917 | 119,214 | 128,203 | 139.1 K to 128.2 K (-7.85 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 0.00 | 23,437 | 0 | 139,120 | 115.7 K to 139.1 K (+20.26 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | A | 10.92 | 289,500 | 3,161,340 | 289,500 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | A | 0.00 | 48,250 | 0 | 48,250 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 11,284 | 0 | 33,854 | |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 10.92 | 5,310 | 57,985 | 191,724 | 197 K to 191.7 K (-2.69 %) |
Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 8.79 | 11,284 | 99,186 | 197,034 | 185.8 K to 197 K (+6.07 %) |